Actress of yesteryear Rekha is among four eminent persons who have been recommended for nomination as members of Rajya Sabha.
Rekha, known for her brilliant and emotional portrayals in Hindi cinema in the 80s, will become member of Parliament under a provision of the constitution that allows the President to nominate 12 members to the Upper House.
There is no word from the Government on who the other two are who have been nominated.
Prime Minister Manmohan Singh sent a communication to the Ministry of Home Affairs on Wednesday which has been sent to President Pratibha Patil for notification, sources said.
Article 80 of the Constitution provides for nomination of persons having special knowledge or practical experience in matters such as literature, science, art and social service.
57-year-old Rekha was one of the top heroines of the 80s in Hindi films and and had won several national awards in her acting career.
The House already has a member from the film world in Javed Akhtar, an eminent lyricist and script writer in Hindi cinema.
Rekha, known for her brilliant and emotional portrayals in Hindi cinema in the 80s, will become member of Parliament under a provision of the constitution that allows the President to nominate 12 members to the Upper House.
There is no word from the Government on who the other two are who have been nominated.
Prime Minister Manmohan Singh sent a communication to the Ministry of Home Affairs on Wednesday which has been sent to President Pratibha Patil for notification, sources said.
Article 80 of the Constitution provides for nomination of persons having special knowledge or practical experience in matters such as literature, science, art and social service.
57-year-old Rekha was one of the top heroines of the 80s in Hindi films and and had won several national awards in her acting career.
The House already has a member from the film world in Javed Akhtar, an eminent lyricist and script writer in Hindi cinema.
Datawind, the company that made headlines with the Aakash tablet, has now announced the launch of two new 7-inch low-cost tablets - the Ubislate 7+ and Ubislate 7C with prices starting at Rs 2999 for the 7+. The 7C model will cost Rs 3,999.
Both the tablets come with similar specifications, only that the Ubislate 7C comes with 4GB of internal flash memory compared to 2GB in the Ubislate 7+.
Both the 7-inch tablets are powered by Cortex A8 800 Mhz processor, 256MB RAM and have an 800x480 pixel capacitive touchscreen. Datawind claims that the 3200 mAh battery will deliver upto 180 minutes of usage. The tablets run on Android 2.3 (Gingerbread)
The tablets have microUSB slots for memory expansion and also include an USB port, that can also be used for optional 3G USB modems.
For customers who have pre-booked the Ubilate 7+ from the Datawind website, the shipmets have already started, said the company and will continue for the next few months before retail availability. The Ubislate 7C will be available from end of May.
Both the Datawind Ubislate 7+ and the Ubislate 7C tablets support WiFi and GPRS (SIM and phone functionality).
Both the tablets come with similar specifications, only that the Ubislate 7C comes with 4GB of internal flash memory compared to 2GB in the Ubislate 7+.
Both the 7-inch tablets are powered by Cortex A8 800 Mhz processor, 256MB RAM and have an 800x480 pixel capacitive touchscreen. Datawind claims that the 3200 mAh battery will deliver upto 180 minutes of usage. The tablets run on Android 2.3 (Gingerbread)
The tablets have microUSB slots for memory expansion and also include an USB port, that can also be used for optional 3G USB modems.
For customers who have pre-booked the Ubilate 7+ from the Datawind website, the shipmets have already started, said the company and will continue for the next few months before retail availability. The Ubislate 7C will be available from end of May.
Both the Datawind Ubislate 7+ and the Ubislate 7C tablets support WiFi and GPRS (SIM and phone functionality).
New Delhi: The Congress has recommended cricketer Sachin Tendulkar's name for the Rajya Sabha and is now waiting for Tendulkar to respond to the same, according to sources. Sources say that Sachin Tendulkar may not accept the nomination. However, an official announcement was awaited.
Sources say that the Congress has offered to nominate him in the President's quota. Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath Residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Sachin has accepted a nomination for Rajya Sabha, according to the update from sources. He is the first active sportsperson and cricketer to have been nominated to the Rajya Sabha.
Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Reacting to the reports of Sachin Tendulkar's proposed nomination, BJP leader Najma Heptulla said, "We are very happy that Tendulkar's name has been proposed for the Rajya Sabha."
"Tendulkar is a great player, we are proud of him. If he is being nominated, surely he would devote some time to Parliament," BJP spokesperson Ravi Shankar Prasad said.
However, the proposal didn't go well with people from the cricket fraternity. Cricket analyst Harsha Bhogle said, "I don't think it is the greatest idea. He doesn't have the experience of governing or doing social work. People are trying to gain mileage out of Tendulkar."
Meanwhile, the Board of Control of Cricket in India (BCCI) welcomed the government's nomination of Tendulkar as a member of the Rajya Sabha, saying that the iconic batsman deserves such an honour.
BCCI Chief Administrative Officer Prof. Ratnakar Shetty said that the Board was happy with the government's move. "We (BCCI) are happy that Tendulkar's services as a sportsperson has been recognised. He's been a true ambassador for the country and he deserves it," he said.
In the past, eminent personalities like directors Shyam Benegal, Mrinal Sen and playback singer Lata Mangeshkar had been the nominated members of the Rajya Sabha.
Sources say that the Congress has offered to nominate him in the President's quota. Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath Residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Sachin has accepted a nomination for Rajya Sabha, according to the update from sources. He is the first active sportsperson and cricketer to have been nominated to the Rajya Sabha.
Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Reacting to the reports of Sachin Tendulkar's proposed nomination, BJP leader Najma Heptulla said, "We are very happy that Tendulkar's name has been proposed for the Rajya Sabha."
"Tendulkar is a great player, we are proud of him. If he is being nominated, surely he would devote some time to Parliament," BJP spokesperson Ravi Shankar Prasad said.
However, the proposal didn't go well with people from the cricket fraternity. Cricket analyst Harsha Bhogle said, "I don't think it is the greatest idea. He doesn't have the experience of governing or doing social work. People are trying to gain mileage out of Tendulkar."
Meanwhile, the Board of Control of Cricket in India (BCCI) welcomed the government's nomination of Tendulkar as a member of the Rajya Sabha, saying that the iconic batsman deserves such an honour.
BCCI Chief Administrative Officer Prof. Ratnakar Shetty said that the Board was happy with the government's move. "We (BCCI) are happy that Tendulkar's services as a sportsperson has been recognised. He's been a true ambassador for the country and he deserves it," he said.
In the past, eminent personalities like directors Shyam Benegal, Mrinal Sen and playback singer Lata Mangeshkar had been the nominated members of the Rajya Sabha.
O2, one of the biggest U.K. Cell phone networks, has realized that it can seize a place in the digital payment revolution by launching its own system...the O2 Wallet. It's a digital charge card system, which you fill up via payments from a traditional credit card, and then you can transfer funds between £1 and £500 between phones and to the websites of over 100 big-name retailers. For now it can't work in stores, but showing the counter-cultural powers of mobile pay the app lets you scan the barcode of an item you like in a store, and then helps you find it cheaper online. Plus NFC capabilities will be added soon to allow in-store purchases. It's clever, and is a taster of bigger things to come, but it's also a demo of how muddied the mobile payment waters are becoming as every enterprise in the race, from operators to phone makers to credit card firms tries to jockey for best position.
It is not news that BlackBerry is lagging behind as far as their operating system is concerned compared to the likes of Android and iOS who have completely dominated the smartphone sphere in recent years. To amend this situation, BlackBerry announced the BlackBerry 10 OS which would put them in contention as a top smartphone manufacturer. Late last year, former Research in Motion CEO stated that the first device running this upcoming operating system would make its first appearance by the end of 2012. However, for those who are eagerly awaiting the BlackBerry 10 OS, it seems that a report by N4BB has some good news as their sources claim that the first handset using this OS will be unveiled by mid-August 2012. This pushes the release date up quite a bit from what was previously believed.
India's mammoth biometrics project, Aadhaar, has been challenged as an expensive undertaking that risked duplicating ID schemes already in place. But a new study suggests that Aadhaar may be on track to reaching its goal of IDing unregistered low-income millions across rural India. A survey of 514,000 households show that 56 percent of Aadhaar enrollees did not have other forms of portable IDs. Lead author Arun Sundararajan from NYU's Stern business school predicts that 300 million Indians without any form of ID would have one by the end of 2012, if signups and enrollments continue in the coming months as expected. "What's important here is that we are not simply seeing people with pre-existing portable ID adding yet another one to their repertoire" Sundararajan said in the release. "Rather, millions of Indians who had no modern form of ID now have one, and this number is growing every month." A form of ID is required to open bank accounts, register for cell phones, and access any kind of government benefit scheme. As enrollment numbers grow--200 million Indians have been enrolled, 170 million have been issued IDs--the Aadhaar system is due to be piloted at banks in 50 districts in India.
HTC and Facebook may be building another phone together, DigiTimes has heard, to launch by Q3 this year. The Android device will have certain Facebook-specific features tucked in. It will be the third phone HTC is working on, after the ChaCha and Salsa. The partnership is an alignment of allies: As Samsung partners with Google for the Nexus series, HTC picks Facebook as a partner.
Facebook is offering Facebookers 6 months' worth of free antivirus software via a new partnership with security champs McAfee, Microsoft, Symantec, Sophos, and TrendMicro. Users can download protection from Facebook's new Antivirus Marketplace, and the antivirus protection won't be confined to user's Facebook pages, rather, the companies will squash web-wide threats. Facebook's massive popularity makes it a target for bad links and spam, something Facebook's been tackling through its partnership with companies like McAfee and Websense. Those security companies scan every link a Facebooker clicks on, and compare it with a "blacklist" of bad sites on their databases. A user is then warned about the site before they can click to proceed. Now, with the free antivirus downloads, it looks like Facebook's taking a broader approach to keeping the social network safe.
Google's just released a new resource for enterprises that are struggling to adapt their business models to address the new mobile technology revolution. In building the Mobile Playbook, Google says it spoke to "hundreds" of companies, and that they "understand that they need to invest in mobile to engage with their customers on this platform. The problem is, most don't know where to start." Hence the HTML5-based resource that Google's put together. It's accessible on tablets, of course, and Google has a vested interest in helping companies go mobile as it supplies the OS behind the majority of the world's smartphones, and also sells billions of mobile ads this way. Keen eyes will spot, however, that Google's example image is of an Apple iPad.
• Amgen (AMGN) Smacks Down $700 Million for Turkey Drugmaker More...
• GlaxoSmithKline (GSK) Insists it is the Best Owner for Human Genome Sciences, Inc. (HGSI) More...
• Targacept, Inc. (TRGT) to Cut 46% Of Workforce After Drug-Trial Setbacks More...
• Gene Ray, Founder of $2.6 Billion Titan Corporation (TTN), Invests in MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)'s ERC Technology and Joins Advisory Board More...
• Vernalis PLC (VNLPY.PK) and Servier Achieve Research Milestone in Drug Discovery Collaboration More...
• AstraZeneca PLC (AZN) and The Medicines Company (MDCO) Announce Global Collaboration in Acute Ischemic Heart Disease More...
• AtheroNova Inc. (AHRO.OB) Signs Agreement for Development of Clinical Trial Supplies More...
• Integral Molecular, Inc. Announces Lipoparticle Distribution in Japan by Funakoshi Co. More...
• Johnson & Johnson (JNJ) CEO Under Fire for Big Bonuses Amid Scandals More...
• Novartis AG (NVS) Tries More Exec Level OTC Switches More...
• Coronado Biosciences Promotes Karin Hehenberger, M.D., Ph.D., to Executive Vice President and Chief Medical Officer More...
• Zyngenia Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer More...
• Threshold Pharmaceuticals, Inc. (THLD) Appoints Robert Simon as Senior Vice President of Regulatory Affairs More...
• Boehringer Ingelheim Corporation's 2011 Profit Jumps 66 Percent More...
• Amgen (AMGN) Posts Strong Drug Sales, Beats Estimates More...
• Amgen (AMGN)'s First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61More...
• Acura Pharmaceuticals, Inc. (ACUR) to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012 More...
• Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports First Quarter 2012 Financial Results and Corporate Updates More...
• ViroPharma Incorporated (VPHM) Loses Bid for Order Blocking Generic Vancocin More...
• Icahn and Amylin Pharmaceuticals, Inc. (AMLN) Have May 10 Hearing for Proxy War More...
• Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. More...
• Precision BioSciences Files Tenth Patent Infringement Lawsuit Against CELLECTIS SA Related to Meganuclease Technology and Requests Permanent Injunction More...
• Pfizer Consumer Healthcare (PFE) Release: The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program More...
• Ipsen Pursues Its Development in the United States With the Opening of Its New Commercial Headquarters in New Jersey (NJ) More...
• Sanofi (France) (SAN.PA)'s Lemtrada Beats Rebif in MS Face-off More...
• Kythera Biopharmaceuticals Announces Positive Results from Two Pivotal European Phase III Trials of ATX-101 for Reduction of Submental Fat More...
• AVI BioPharma, Inc. (AVII) to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting More...
• Repligen Corporation (RGEN) Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy More...
• Ablynx Release: Nanobody for Alzheimer's Disease From the Alliance With Boehringer Ingelheim Corporation Moves Closer Towards Phase I Clinical Trials More...
• American Regent, Inc. Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1 mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles More...
• Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease More...
• Salix Pharmaceuticals, Ltd. (SLXP), Progenics Pharmaceuticals, Inc. (PGNX) Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 More...
• Fish Oil Could be Therapy for Periodontal Disease, University of South Australia Reveals More...
• Botox Ingredient Has Limited Effect on Headaches, Medical College of Wisconsin Study More...
• Does Fatty Food Impact Marital Stress? Ohio State University Medical Center Study More...
• Signs of Early DNA "Aging" in Abused Kids, Duke University Study More...
• Evaluating the First Drug to Show Improvement in Subtype of Autism, Mount Sinai School of Medicine Study More...
• VistaGen Therapeutics, Inc. Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity More...
• Lpath, Inc. Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab More...
• Metabolix, Inc. Awarded Two U.S. Patents for Technology to Produce Biobased Polymers and Industrial Chemicals More...
• BioLineRx Ltd. Announces Extension of Patent for BCM (BL-1040) by USPTO More...
• Marshall Edwards, Inc. (MSHL) Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer More...
• Novartis AG (NVS)'s Gilenya Given Final Approval by UK's Cost Agency More...
• PuraMed BioScience Continues to Build Awareness for LipiGesic(R) M Through Media Campaigns More...
• New Products from Abbott Laboratories (ABT)'s EAS(R) Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals More...
• GlaxoSmithKline (GSK) Insists it is the Best Owner for Human Genome Sciences, Inc. (HGSI) More...
• Targacept, Inc. (TRGT) to Cut 46% Of Workforce After Drug-Trial Setbacks More...
• Gene Ray, Founder of $2.6 Billion Titan Corporation (TTN), Invests in MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)'s ERC Technology and Joins Advisory Board More...
• Vernalis PLC (VNLPY.PK) and Servier Achieve Research Milestone in Drug Discovery Collaboration More...
• AstraZeneca PLC (AZN) and The Medicines Company (MDCO) Announce Global Collaboration in Acute Ischemic Heart Disease More...
• AtheroNova Inc. (AHRO.OB) Signs Agreement for Development of Clinical Trial Supplies More...
• Integral Molecular, Inc. Announces Lipoparticle Distribution in Japan by Funakoshi Co. More...
• Johnson & Johnson (JNJ) CEO Under Fire for Big Bonuses Amid Scandals More...
• Novartis AG (NVS) Tries More Exec Level OTC Switches More...
• Coronado Biosciences Promotes Karin Hehenberger, M.D., Ph.D., to Executive Vice President and Chief Medical Officer More...
• Zyngenia Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer More...
• Threshold Pharmaceuticals, Inc. (THLD) Appoints Robert Simon as Senior Vice President of Regulatory Affairs More...
• Boehringer Ingelheim Corporation's 2011 Profit Jumps 66 Percent More...
• Amgen (AMGN) Posts Strong Drug Sales, Beats Estimates More...
• Amgen (AMGN)'s First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61More...
• Acura Pharmaceuticals, Inc. (ACUR) to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012 More...
• Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports First Quarter 2012 Financial Results and Corporate Updates More...
• ViroPharma Incorporated (VPHM) Loses Bid for Order Blocking Generic Vancocin More...
• Icahn and Amylin Pharmaceuticals, Inc. (AMLN) Have May 10 Hearing for Proxy War More...
• Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. More...
• Precision BioSciences Files Tenth Patent Infringement Lawsuit Against CELLECTIS SA Related to Meganuclease Technology and Requests Permanent Injunction More...
• Pfizer Consumer Healthcare (PFE) Release: The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program More...
• Ipsen Pursues Its Development in the United States With the Opening of Its New Commercial Headquarters in New Jersey (NJ) More...
• Sanofi (France) (SAN.PA)'s Lemtrada Beats Rebif in MS Face-off More...
• Kythera Biopharmaceuticals Announces Positive Results from Two Pivotal European Phase III Trials of ATX-101 for Reduction of Submental Fat More...
• AVI BioPharma, Inc. (AVII) to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting More...
• Repligen Corporation (RGEN) Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy More...
• Ablynx Release: Nanobody for Alzheimer's Disease From the Alliance With Boehringer Ingelheim Corporation Moves Closer Towards Phase I Clinical Trials More...
• American Regent, Inc. Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1 mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles More...
• Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease More...
• Salix Pharmaceuticals, Ltd. (SLXP), Progenics Pharmaceuticals, Inc. (PGNX) Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 More...
• Fish Oil Could be Therapy for Periodontal Disease, University of South Australia Reveals More...
• Botox Ingredient Has Limited Effect on Headaches, Medical College of Wisconsin Study More...
• Does Fatty Food Impact Marital Stress? Ohio State University Medical Center Study More...
• Signs of Early DNA "Aging" in Abused Kids, Duke University Study More...
• Evaluating the First Drug to Show Improvement in Subtype of Autism, Mount Sinai School of Medicine Study More...
• VistaGen Therapeutics, Inc. Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity More...
• Lpath, Inc. Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab More...
• Metabolix, Inc. Awarded Two U.S. Patents for Technology to Produce Biobased Polymers and Industrial Chemicals More...
• BioLineRx Ltd. Announces Extension of Patent for BCM (BL-1040) by USPTO More...
• Marshall Edwards, Inc. (MSHL) Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer More...
• Novartis AG (NVS)'s Gilenya Given Final Approval by UK's Cost Agency More...
• PuraMed BioScience Continues to Build Awareness for LipiGesic(R) M Through Media Campaigns More...
• New Products from Abbott Laboratories (ABT)'s EAS(R) Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals More...
